#1 Clinical Trials Search in Europe

Cefalexin Monohydrate

This article examines the use of Cefalexin Monohydrate, an antibiotic medication, in various clinical trials. Cefalexin Monohydrate has been studied for its effectiveness in treating bone and joint infections in children, preventing urinary tract infections in patients using intermittent catheterization, and preventing infections after cardiac device implantation. The trials aim to determine optimal dosing regimens, compare oral versus intravenous administration, and evaluate its efficacy compared to other antibiotics.

Table of Contents

What is Cefalexin?

Cefalexin monohydrate, also known by brand names such as Keflex and Optocef, is an antibiotic medication belonging to the cephalosporin class[4][5]. It is used to treat various bacterial infections. Cefalexin works by stopping the growth of bacteria, helping your body’s immune system to fight off the infection.

Uses of Cefalexin

Cefalexin is prescribed for several types of bacterial infections, including:

  • Bone and joint infections (BJIs): These are serious infections affecting the bones and joints. Cefalexin can be used as part of the treatment for these conditions[1].
  • Urinary tract infections (UTIs): Cefalexin may be used to prevent recurrent UTIs in some patients[2].
  • Skin and soft tissue infections: These can include cellulitis, abscesses, and other bacterial skin infections.
  • Respiratory tract infections: Such as bronchitis or pneumonia caused by susceptible bacteria.

How Cefalexin is Administered

Cefalexin is available in different forms and dosages:

  • Capsules: Usually available in 250mg and 500mg strengths[5].
  • Oral suspension: Liquid form, often used for children or those who have difficulty swallowing capsules. It comes in concentrations of 125mg/5mL or 250mg/5mL[4].

The dosage and duration of treatment will depend on the type and severity of the infection, as well as other factors determined by your healthcare provider. It’s important to complete the full course of antibiotics as prescribed, even if you start feeling better before finishing the medication.

Cefalexin in Clinical Trials

Several clinical trials have been conducted to study the effectiveness and safety of cefalexin in various conditions:

  • Bone and Joint Infections in Children: A trial is comparing oral cefalexin treatment to intravenous antibiotics followed by oral cefalexin for children with bone and joint infections[1].
  • Prevention of Urinary Tract Infections: Cefalexin is being studied as a preventive treatment for recurrent UTIs in people who use intermittent catheterization[2].
  • Prevention of Cardiac Device Infections: Cefalexin is being investigated as part of an antibiotic regimen to prevent infections after implantation of cardiac devices like pacemakers[3].

Potential Side Effects

Like all medications, cefalexin can cause side effects, although not everyone experiences them. Common side effects may include:

  • Gastrointestinal issues (e.g., nausea, diarrhea)
  • Allergic reactions (e.g., rash, itching)
  • Yeast infections

If you experience severe side effects or signs of an allergic reaction, seek medical attention immediately[4][5].

Precautions and Considerations

When taking cefalexin, keep in mind:

  • Inform your healthcare provider about any allergies, especially to antibiotics.
  • Discuss all medications, supplements, and herbal products you’re taking with your doctor.
  • Cefalexin may interact with certain laboratory tests, potentially causing false results.
  • Take the medication as prescribed, and complete the full course of treatment.
  • If you miss a dose, take it as soon as you remember, unless it’s almost time for your next dose. In that case, skip the missed dose and continue with your regular schedule.

Remember, cefalexin is a prescription medication and should only be taken under the guidance of a healthcare professional. If you have any questions or concerns about your treatment, always consult with your doctor or pharmacist.

Trial Focus Cefalexin Monohydrate Use Key Findings/Objectives
Bone and Joint Infections in Children Oral cefalexin 37.5 mg/kg/dose (max 1.5 g) QID for 1-7 days, followed by 45 mg/kg/dose (max 1.5 g) TDS for 3 weeks Comparing entirely oral antibiotic treatment to initial IV treatment followed by oral antibiotics
Urinary Tract Infection Prevention Daily antibiotic prophylaxis: cefalexin 250 mg Assessing effectiveness in preventing recurrent UTIs in patients using intermittent catheterization
Cardiac Device Infection Prevention Cefalexin 500 mg QID for 5 days post-implantation Evaluating the impact of post-procedural antibiotic treatment on infection rates
Bioequivalence Studies Single doses of 500 mg in capsule or suspension form Comparing bioavailability between different brands and formulations of cefalexin

FAQ

  • What is Cefalexin Monohydrate used for in clinical trials? Cefalexin Monohydrate is being studied for treating bone and joint infections in children, preventing urinary tract infections in patients using intermittent catheterization, and preventing infections after cardiac device implantation.
  • How is Cefalexin Monohydrate administered in these trials? In the trials, Cefalexin Monohydrate is administered orally in various doses, ranging from 37.5 mg/kg to 500 mg, depending on the study and patient group.
  • What are the potential benefits of using Cefalexin Monohydrate? Potential benefits include effective treatment of infections, prevention of recurrent urinary tract infections, and reduction of infection risk after cardiac device implantation.
  • Are there any side effects associated with Cefalexin Monohydrate in these trials? While specific side effects are not detailed in the trial summaries, the studies monitor for adverse events related to antibiotic use, which may include gastrointestinal issues or allergic reactions.
  • How long do patients typically take Cefalexin Monohydrate in these trials? The duration of Cefalexin Monohydrate use varies by trial, ranging from single doses in bioequivalence studies to 3-week courses for bone and joint infections, and up to 12 months for urinary tract infection prevention.

Ongoing Clinical Trials on Cefalexin Monohydrate

  • Comparing local gentamicin or vancomycin hydrochloride to a drug combination for patients with diabetic foot osteomyelitis

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Finland

  • Study on Fluconazole and Cefalexin Monohydrate for Treating Laryngeal Leukoplakia in Adults

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Finland

Glossary

  • Cefalexin Monohydrate: An antibiotic medication belonging to the cephalosporin class, used to treat various bacterial infections.
  • Bone and Joint Infections (BJIs): Infections that affect the bones and/or joints, which can be serious and may require prolonged antibiotic treatment.
  • Clean Intermittent Self-Catheterisation (CISC): A technique where individuals regularly insert a catheter to empty their bladder, often used by those with bladder control issues.
  • Urinary Tract Infection (UTI): An infection affecting any part of the urinary system, including the kidneys, bladder, or urethra.
  • Antibiotic Prophylaxis: The use of antibiotics to prevent infections before they occur, often used in high-risk situations or procedures.
  • Cardiac Implantable Electronic Device: A medical device implanted in the chest to help control heart rhythm, such as a pacemaker or defibrillator.
  • Bioequivalence: The property of two drug products having the same biological effect and availability in the body when administered at the same dose.
  • Pharmacokinetics: The study of how a drug moves through the body, including its absorption, distribution, metabolism, and excretion.
  • Adverse Event: Any unfavorable and unintended sign, symptom, or disease temporarily associated with the use of a medical treatment or procedure.
  • Randomized Controlled Trial: A type of scientific experiment where participants are randomly assigned to different treatment groups to compare the effectiveness of interventions.

References

  1. https://clinicaltrials.gov/study/NCT04538053
  2. https://clinicaltrials.gov/study/NCT02145338
  3. https://clinicaltrials.gov/study/NCT01002911
  4. https://clinicaltrials.gov/study/NCT01105208
  5. https://clinicaltrials.gov/study/NCT01073553